This site is intended only for healthcare professionals resident in the United Kingdom

Information relating to specific disease areas aligned to Pfizer’s portfolio and other resources designed for Pfizer medicines.

See all Therapy areas

Click here for BeneFIX® (nonacog alfa) Prescribing Information.  Adverse event reporting information can be found at the bottom of the page.

Benefix

Dosing that’s as individual as your patients1–3​​​​​​​

Information on flexible dosing and achieving medicines opimisation with BeneFIX.

Find out more

Reliable efficacy when you and your patients need it most4-6

Information on BeneFIX efficacy for Prophylaxis and On-Demand treatment.

Find out more

Downloadable patient materials

Access materials to support your haemophilia patients.

View  materials

Explore more

Administration & reconstitution

Step by step instructions on the reconstitution of BeneFIX for injection, using the R2 device

Find out more

Educational materials for children with haemophilia

Find out more

Contact Pfizer

Speak to a member of the Pfizer Haemophilia team.

Click here


References
  1. BeneFIX (nonacog alfa) Summary of Product Characteristics: https://www.medicines.org.uk/emc/product/6157/smpc.
  2. Shapiro AD et al. Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia. Haemophilia 2005;11:571–582.
  3. Berntorp E and Andersson NG. Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products. Semin Thromb Hemost 2016;42:518–525.
  4. Roth DA et al. Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates. Blood 2001;98(13):3600–3606.
  5. Shapiro AD et al. The safety and efficacy of recombinant human blood coagulation factor IX in previously untreated patients with severe or moderately severe hemophilia B. Blood 2005;105(2):518–525.
  6. Ragni MV et al. Use of recombinant factor IX in subjects with haemophilia B undergoing surgery. Haemophilia 2002;8(2):91–97.
PP-BEN-GBR-0389. March 2021

For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-2688. December 2020

Yes

No